[PHARMA] QoQ TTM Result on 30-Sep-2018 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- 23.77%
YoY- 91.53%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 2,572,302 2,553,141 2,384,956 2,401,508 2,388,351 2,323,589 2,323,960 7.02%
PBT 72,267 71,756 70,220 78,146 75,814 73,994 73,064 -0.73%
Tax -23,482 -26,467 -26,990 -17,398 -26,481 -20,676 -18,077 19.10%
NP 48,785 45,289 43,230 60,748 49,333 53,318 54,987 -7.68%
-
NP to SH 48,386 44,499 42,468 59,731 48,260 52,386 53,723 -6.75%
-
Tax Rate 32.49% 36.88% 38.44% 22.26% 34.93% 27.94% 24.74% -
Total Cost 2,523,517 2,507,852 2,341,726 2,340,760 2,339,018 2,270,271 2,268,973 7.36%
-
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
Dividend
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Div 40,348 44,226 41,587 51,957 51,929 51,913 49,290 -12.52%
Div Payout % 83.39% 99.39% 97.93% 86.99% 107.60% 99.10% 91.75% -
Equity
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Net Worth 518,564 528,825 509,862 522,618 519,642 524,838 526,888 -1.05%
NOSH 261,229 260,505 260,505 260,505 259,821 259,821 259,821 0.36%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 1.90% 1.77% 1.81% 2.53% 2.07% 2.29% 2.37% -
ROE 9.33% 8.41% 8.33% 11.43% 9.29% 9.98% 10.20% -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 987.13 980.07 916.82 923.62 919.23 894.30 895.38 6.73%
EPS 18.57 17.08 16.33 22.97 18.57 20.16 20.70 -7.00%
DPS 15.50 17.00 16.00 20.00 20.00 20.00 19.00 -12.72%
NAPS 1.99 2.03 1.96 2.01 2.00 2.02 2.03 -1.32%
Adjusted Per Share Value based on latest NOSH - 260,505
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 178.48 177.15 165.48 166.63 165.72 161.22 161.25 7.02%
EPS 3.36 3.09 2.95 4.14 3.35 3.63 3.73 -6.74%
DPS 2.80 3.07 2.89 3.61 3.60 3.60 3.42 -12.51%
NAPS 0.3598 0.3669 0.3538 0.3626 0.3606 0.3642 0.3656 -1.06%
Price Multiplier on Financial Quarter End Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 -
Price 2.84 2.27 2.78 2.89 2.88 4.28 4.60 -
P/RPS 0.29 0.23 0.30 0.31 0.31 0.48 0.51 -31.43%
P/EPS 15.29 13.29 17.03 12.58 15.51 21.23 22.22 -22.11%
EY 6.54 7.53 5.87 7.95 6.45 4.71 4.50 28.39%
DY 5.46 7.49 5.76 6.92 6.94 4.67 4.13 20.51%
P/NAPS 1.43 1.12 1.42 1.44 1.44 2.12 2.27 -26.57%
Price Multiplier on Announcement Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 23/08/19 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 -
Price 2.66 2.36 2.76 3.09 3.11 4.07 4.04 -
P/RPS 0.27 0.24 0.30 0.33 0.34 0.46 0.45 -28.92%
P/EPS 14.33 13.82 16.91 13.45 16.74 20.19 19.52 -18.66%
EY 6.98 7.24 5.92 7.43 5.97 4.95 5.12 23.01%
DY 5.83 7.20 5.80 6.47 6.43 4.91 4.70 15.49%
P/NAPS 1.34 1.16 1.41 1.54 1.56 2.01 1.99 -23.23%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment